Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether computer bias modification for interpretation bias (CBM-I) is effective in the reduction of suicidal ideation in substance use disorders.

Clinical Trial Description

Eighty-eight adult inpatients completing residential treatment in the Addictions Services at the Centre for Addiction and Mental Health (CAMH) will be randomized to receive CBM-I daily for one week, adjunct to the residential psychosocial treatment or to an assessment-only control condition. Participants will complete clinical measures consisting of interviews and questionnaires measuring suicidal ideation, hopelessness, depression, negative affect, and interpretation biases before, during and after treatment. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03000699
Study type Interventional
Source Centre for Addiction and Mental Health
Status Completed
Phase N/A
Start date March 1, 2017
Completion date December 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT00887367 - EtOH Interaction Study Phase 1
Completed NCT01036061 - GSK618334 Repeat Dose Study Phase 1
Completed NCT01381133 - Adolescent Outpatient and Continuing Care Study Phase 3
Completed NCT01128140 - Efficacy Trial of Warrior Check-Up Phase 2
Active, not recruiting NCT03767907 - Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial N/A
Withdrawn NCT01515917 - Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI) N/A
Completed NCT00208143 - Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia Phase 4
Completed NCT03762798 - Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone N/A
Completed NCT03048552 - Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3 N/A
Withdrawn NCT00908206 - Effects of GSK598809 on Brain Activation in Abstinent Alcoholics Phase 1
Recruiting NCT01741415 - Distress Tolerance Treatment for Substance Users Phase 2
Active, not recruiting NCT01621711 - Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care N/A
Active, not recruiting NCT00609089 - Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction Phase 1/Phase 2
Completed NCT00288886 - Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment Phase 2
Completed NCT00208195 - Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase 4
Completed NCT00437840 - A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809 Phase 1
Recruiting NCT04768920 - Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD) N/A
Completed NCT00437632 - Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809 Phase 1
Completed NCT00728052 - A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers Phase 1
Completed NCT00513279 - To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334 Phase 1